Role of superoxide and thromboxane receptors in acute angiotensin II-induced vasoconstriction of rabbit vessels

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 6, 2011, Pages

  Pfister, Sandra L ^a   Nithipatikom, Kasem ^a   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Arachidonic acid; Isoprostane; Oxidative stress

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ANGIOTENSIN II; ARACHIDONIC ACID; DAZOXIBEN; INDOMETACIN; ISOPROSTANE DERIVATIVE; N(G) NITROARGININE; SUPEROXIDE DISMUTASE; THROMBOXANE RECEPTOR; TIRON; XANTHINE OXIDASE;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; ARACHIDONIC ACID; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; IMIDAZOLES; INDOMETHACIN; ISOPROSTANES; MALE; MESENTERIC ARTERIES; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; RABBITS; RECEPTORS, THROMBOXANE; SUPEROXIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 79958028562     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01135.2010     Document Type: Article

References (40)

1. Aggarwal NT, Pfister SL, Gauthier KM, Chawenginf Y, Baker JE, Campbell WB. Chronic hypoxia enhances 15-lipoxygenase-mediated vasorelaxation in rabbit arteries. Am J Physiol Heart Circ Physiol 296: H678-H688, 2009.
2. 2. J Pharmacol Exp Ther 236: 535-541, 1986.
3. Basu S. Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic Res 38: 105-122, 2004.
4. 2. Circ Res 72: 1023-1034, 1993.
5. 2 mimetic. Am J Physiol Heart Circ Physiol 266: H2320-H2326, 1994.
6. Fam SS, Morrow JD. The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem 10: 1723-1740, 2003.
7. Francois H, Athirakul K, Mao L, Rockman H, Coffman TM. Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 43: 364-369, 2004.
8. Garrido AM, Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302: 148-158, 2009.
9. Haas JA, Krier JD, Bolterman RJ, Juncos LA, Romero JC. Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension 34: 983-986, 1999.
10. Janssen L, Tazzeo T. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J Pharmacol Exp Ther 301: 1030-1066, 2002.
11. Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280: L1067-L1082, 2001.
12. Kawada N, Dennehy K, Solis G, Modlinger P, Hamel R, Kawada JT, Aslam S, Moriyama T, Imai E, Welch WJ, Wilcox CS. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am J Physiol Renal Physiol 287: F753-F759, 2004.
13. Keen HL, Brands MW, Smith MJJ, Shek EW, Hall JE. Thromboxane is required for full expression of angiotensin hypertension in rats. Hypertension 29: 310-314, 1997.
14. 2 alpha. J Pharmacol Exp Ther 281: 957-964, 1997.
15. Li H, Lawson JA, Reilly M, Adiyaman M, Hwang SW, Rokach J, FitzGerald GA. Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine. Proc Natl Acad Sci USA 96: 13381-13386, 1999.
16. 2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. Prostaglandins 48: 247-256, 1994.
17. Mistry M, Muirhead EE, Yamaguchi Y, Nasjletti A. Renal function in rats with angiotensin II-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockade. J Hypertens 8: 75-83, 1990.
18. 2-isoprostanes in salt-replete human hypertensives. Free Radic Biol Med 35: 711-718, 2003.
19. Murphy R, Barkley R, Zemski Berry K, Hankin J, Harrison K, Johnson C, Krank J, McAnoy A, Uhlson C, Zarini S. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal Biochem 346: 1-42, 2005.
20. Nithipatikom K, Grall A, Holmes B, Harder D, Falck J, Campbell W. Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid. Anal Biochem 298: 327-336, 2001.
21. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA 94: 14483-14488, 1997.
22. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, Cohen RA. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol Heart Circ Physiol 268: H2274-H2280, 1995.
23. Pfister SL. Aortic thromboxane receptor deficiency alters vascular reactivity in cholesterol-fed rabbits. Atherosclerosis 189: 358-363, 2006.
24. Pfister SL. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 43: 428-433, 2004.
25. 2 receptors mediate arachidonic acid-induced sudden death in rabbits. Hypertension 29: 303-309, 1997.
26. Pfister SL, Spitzbarth N, Nithipatikom K, Edgemond WS, Falck JR, Campbell WB. Identification of 11,14,15- and 11,12,15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J Biol Chem 273: 30879-30887, 1998.
27. Quilley J, McGiff JC, Nasjletti A. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Br J Pharmacol 96: 111-116, 1989.
28. Raij L. Workshop: hypertension and cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction. Hypertension 37: 767-773, 2001.
29. Reckelhoff JF, Zhang H, Srivastava K, Roberts LJ II, Morrow JD, Romero JC. Subpressor doses of angiotensin II increase plasma F(2)- isoprostanes in rats. Hypertension 35: 476-479, 2000.
30. Roberts LJ II, Fessel JP. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids 128: 173-186, 2004.
31. Sametz W, Grobuschek T, Hammer-Kogler S, Juan H, Wintersteiger R. Influence of isoprostanes on vasoconstrictor effects of noradrenaline and angiotensin II. Eur J Pharmacol 378: 47-55, 1999.
32. 2alpha, in some isolated smooth muscle preparations. Br J Pharmacol 130: 1903-1910, 2000.
33. _ and NO. Am J Physiol Renal Physiol 279: F302-F308, 2000.
34. Schulman IH, Zhou MS, Raij L. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension. J Hypertens Suppl 24: S45-S50, 2006.
35. 2 receptors. J Clin Invest 90: 136-141, 1992.
36. Wang D, Chabrashvili T, Wilcox CS. Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium. Circ Res 94: 1436-1442, 2004.
37. Wilcox CS, Welch WJ. Thromboxane mediation of the pressor response to infused angiotensin II. Am J Hypertens 3: 242-249, 1990.
38. Wilcox CS, Welch WJ, Snellen H. Thromboxane mediates renal hemodynamic response to infused angiotensin II. Kidney Int 40: 1090-1097, 1991.
39. 2 receptors. J Pharmacol Exp Ther 263: 905-909, 1992.
40. Zhang DX, Zou AP, Li PL. Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries. Am J Physiol Heart Circ Physiol 284: H605-H612, 2003.